SCHEMBL20324732

Nc1nc2c(ncn2[C@H]2CC[C@@H](COP(=O)(O)OC3[C@@H](O)[C@H](n4ccc5c(Cl)ncnc54)O[C@@H]3COP(=O)(O)O)O2)c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	P2RY2	P41231	1/20	0.52

▸	P2RY4	P51582	1/20	0.52

▸	P2RY6	Q15077	1/20	0.52

▸	RNASEL	Q05823	7/20	0.51

▸	TGM2	P21980	1/20	0.47

▸	NT5E	P21589	1/20	0.47

▸	F2	P00734	1/20	0.47

▸	FUT5	Q11128	1/20	0.47

▸	TAS1R3	Q7RTX0	1/20	0.46

▸	TAS1R1	Q7RTX1	1/20	0.46

▸	KRAS	P01116	1/20	0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL20324735	0.89	RNASEL (0.62)	P2RY2RNASELTAS1R3TAS1R1
SCHEMBL20327591	0.86	FUT5 (0.47)	P2RY2P2RY4P2RY6RNASELTGM2
SCHEMBL20324882	0.85	RNASEL (0.56)	P2RY2RNASELTAS1R3TAS1R1
SCHEMBL20327588	0.84	P2RY2 (0.48)	P2RY2P2RY4P2RY6RNASELTGM2
SCHEMBL20763046	0.84	FUT5 (0.57)	P2RY2P2RY4P2RY6RNASELTGM2
SCHEMBL20324890	0.83	STING1 (0.52)	P2RY2P2RY4P2RY6RNASELTGM2
SCHEMBL20327583	0.83	STING1 (0.52)	P2RY2P2RY4P2RY6RNASELTGM2
SCHEMBL22399223	0.83	RNASEL (0.54)	RNASELTGM2NT5ETAS1R3TAS1R1
SCHEMBL18510943	0.83	RNASEL (0.59)	P2RY2P2RY4P2RY6RNASELTGM2
SCHEMBL20324866	0.83	RNASEL (0.55)	RNASEL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2018118664-A1	COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT	MERCK SHARP & DOHME CORP. (US)	2018-06-28	—	—	WO	disclosed